Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

Recent research from Karl Landsteiner University of Health Sciences (KL Krems) provides important new insights into how ...

Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...

Aortic valve size determines the degree of valve calcification in severe aortic stenosis: KL Krems research: Krems, Austria Saturday, March 15, 2025, 13:00 Hrs [IST] Recent resear ...

Aortic stenosis, a narrowing of the aortic valve, is one of the most common and severe structural issues, particularly in ...

The data raise questions about valve hemodynamics and the role of early imaging to stay ahead of clinical and subclinical ...

Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction ...

The preliminary results look promising for the Evolut for specific patients. The trial consists of mostly women, who have ...